Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms, Castration-Resistant

Explore clinical trials studying Prostatic Neoplasms, Castration-Resistant. Study availability and eligibility vary by location and protocol.

57 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms, Castration-Resistant trial results

Recruiting

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

NCT05393791

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Border Medical Oncology Research Unit / The Border Cancer Hospital Albury, New South Wales, Australia
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • St George Hospital Kogarah, New South Wales, Australia
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
View all 19 locations
View Trial Details
Completed

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT05848011

Conditions
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, +17 more
Locations
  • United Medical Group Miami, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 61 locations
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT04428788

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Local Institution - 116 Stanford, California, United States
  • Local Institution - 122 Washington D.C., District of Columbia, United States
  • Local Institution - 103 Sarasota, Florida, United States
  • Local Institution - 121 Thomasville, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions